Mark Bodmer - CSO, President of R&D at Evelo Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CSO, President of R&D
Stock Symbol
EVLO on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Bodmer since 12/17/2023

Holdings reported by Mark Bodmer for Evelo Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25.7K $8.49K $0.33 Nov 8, 2023 Direct
Restricted Stock Units 6.63K Nov 7, 2023 Direct Common Stock

Transactions reported by Mark Bodmer for Evelo Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.